Day One Biopharmaceuticals (NASDAQ:DAWN) Given Buy Rating at HC Wainwright
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a report issued on Thursday,Benzinga reports. They ...
JonesTrading Sticks to Their Buy Rating for Day One Biopharmaceuticals (DAWN)
In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Day One Biopharmaceuticals (DAWN – Research Report), with a ...
Charles Schwab Investment Management Inc. Raises Stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Charles Schwab Investment Management Inc. boosted its holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) by 5.5% during the 4th quarter, according to its most recent disclosure ...